A blood cancer diagnosis can feel especially frightening. Dr. Bedi's Royal Marsden training in haemato-oncology equips him to guide you with clarity and confidence.
Blood cancers — leukaemia, lymphoma, and myeloma — affect how your body makes and uses blood cells. They range from highly curable (Hodgkin lymphoma) to chronic conditions manageable for years. Treatment advances have improved outcomes dramatically across all types.
Dr. Bedi's Royal Marsden training gives him specialised depth in blood cancers that few in the region can match.
From aggressive induction for acute leukaemia to gentler approaches for chronic conditions — balancing effectiveness with quality of life.
Monoclonal antibodies and small-molecule inhibitors have revolutionised treatment for many lymphomas and leukaemias.
For eligible patients, bone marrow transplant offers the possibility of cure. Fortis coordinates the full journey.
Cancers like CLL may not need immediate treatment. Dr. Bedi monitors carefully, intervening only when needed.
Blood cancers are where my training began — at AIIMS and then Royal Marsden, surrounded by the world's leading haematologists. Many blood cancers are among the most treatable we see.
No. Many forms are highly treatable. Acute lymphoblastic leukaemia in younger patients has cure rates exceeding 80%.
Hodgkin lymphoma has very high cure rates. Non-Hodgkin is broader with varying prognoses — many are very treatable.
High-dose chemo followed by infusion of healthy stem cells to rebuild bone marrow. Dr. Bedi explains if this fits your case.
Possible, which is why follow-up monitoring is important. Dr. Bedi creates a personalised surveillance plan.
Dr. Bedi and his team are here to listen, answer your questions, and build a path forward — together.